Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lexeo Therapeutics, Inc. - Common Stock (NQ: LXEO ) 12.21 +0.11 (+0.91%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lexeo Therapeutics, Inc. - Common Stock LXEO Stock Earnings: Lexeo Therapeutics Beats EPS for Q2 2024 August 12, 2024 LXEO stock results show that Lexeo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results July 15, 2024 Via Benzinga Exposures Fossil Fuels Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 15, 2024 Via Benzinga Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet July 15, 2024 Via Benzinga Why Top 4% Biotech Stock Lexeo Therapeutics Just Gave Up A Breakout July 15, 2024 The company is in the early stages of testing a gene therapy for the heart complications of a genetic disease. Via Investor's Business Daily Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July July 15, 2024 Via Benzinga Topics Stocks Exposures US Equities Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights May 09, 2024 From Lexeo Therapeutics Via GlobeNewswire Lexeo Therapeutics to Participate in Upcoming Investor Conferences May 07, 2024 From Lexeo Therapeutics Via GlobeNewswire Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday April 22, 2024 Via Benzinga Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy April 22, 2024 From Lexeo Therapeutics Via GlobeNewswire Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy April 16, 2024 From Lexeo Therapeutics Via GlobeNewswire Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing March 13, 2024 Lexeo extends runway into 2027 with private placement co-led by Braidwell LP and Adage Capital Partners LP with participation from new and existing investors including RA Capital Management, Surveyor... From Lexeo Therapeutics Via GlobeNewswire RBC Capital Maintains Outperform Rating for Lexeo Therapeutics: Here's What You Need To Know March 12, 2024 Via Benzinga Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights March 11, 2024 From Lexeo Therapeutics Via GlobeNewswire Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing March 11, 2024 Lexeo extends runway into 2027 with private placement co-led by Braidwell LP and Adage Capital Partners LP, with participation from new and existing investors including RA Capital Management, Surveyor... From Lexeo Therapeutics Via GlobeNewswire Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday March 06, 2024 U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments February 05, 2024 From Lexeo Therapeutics Via GlobeNewswire Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 18, 2024 Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the... Via Benzinga Fastenal Posts Upbeat Earnings, Joins NovoCure, Taiwan Semiconductor Manufacturing And Other Big Stocks Moving Higher On Thursday January 18, 2024 U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Thursday. Shares of Fastenal Company (NASDAQ: FAST) rose during Thursday’s session after the company reported... Via Benzinga Topics Stocks Exposures US Equities Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From LEXEO Therapeutics Via GlobeNewswire Marathon Digital, Canaan, CleanSpark And Other Big Stocks Moving Lower On Tuesday December 26, 2023 U.S. stocks traded higher, with the Dow Jones index gaining around 40 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga Topics Stocks Exposures US Equities Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM) December 18, 2023 From LEXEO Therapeutics Via GlobeNewswire LXEO Stock Earnings: Lexeo Therapeutics Reported Results for Q3 2023 December 11, 2023 Lexeo Therapeutics just reported results for the third quarter of 2023. Via InvestorPlace Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights December 11, 2023 From LEXEO Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session December 01, 2023 Via Benzinga Pineapple Financial Drops In Trading Debut November 05, 2023 Shares of Pineapple Financial slipped over 25% in their trading debut following a downsized IPO. The tech-focused mortgage brokerage had cut the size of its offering from 1.25 million to 875,000 common... Via Talk Markets Topics Initial Public Offering Exposures Securities Market Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.